- Abstract:
- Near-patient testing (NPT) is increasingly being used in the management of chronic conditions. In COPD, NPT devices include the spirometer and saturation probe, but these do not directly guide treatment. The blood eosinophil count at a cut off of ≥2% has been shown to determine which patients should receive corticosteroids for exacerbations. An NPT that accurately correlates with whole blood eosinophil counts would be useful.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Publisher:
- European Respiratory Society Publisher's website
- Volume:
- 48
- Issue:
- suppl 60
- Pages:
- PA903
- Publication date:
- 2016-11-08
- Acceptance date:
- 2016-08-01
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
- Pubs id:
-
pubs:921682
- URN:
-
uri:8a4d851d-0af0-47f7-a4ea-2c2658040bf5
- UUID:
-
uuid:8a4d851d-0af0-47f7-a4ea-2c2658040bf5
- Local pid:
- pubs:921682
- Keywords:
- Copyright holder:
- Hambleton et al
- Copyright date:
- 2016
- Notes:
-
Copyright ©the authors 2016. This is the accepted manuscript version of the article. The final version is available online from the European Respiratory Society at: https://doi.org/10.1183/13993003.congress-2016.PA903
This abstract was presented at the European Respiratory Society International Congress 2016
Conference item
Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record